Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial

Robin Daniel Kjersgaard Christensen, Simon Tarp, Daniel E Furst, Lars Erik Kristensen, Henning Bliddal

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of infliximab or adalimumab, versus abatacept, in patients with rheumatoid arthritis: ATTEST–AMPLE network randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences